vs
瑞思迈（RMD）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
RENAISSANCERE HOLDINGS LTD的季度营收约是瑞思迈的1.5倍（$2.2B vs $1.4B），瑞思迈净利率更高（27.6% vs 23.5%，领先4.1%），瑞思迈同比增速更快（11.0% vs -36.8%），过去两年瑞思迈的营收复合增速更高（9.0% vs -11.9%）
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
RMD vs RNR — 直观对比
营收规模更大
RNR
是对方的1.5倍
$1.4B
营收增速更快
RMD
高出47.7%
-36.8%
净利率更高
RMD
高出4.1%
23.5%
两年增速更快
RMD
近两年复合增速
-11.9%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $2.2B |
| 净利润 | $392.6M | $515.8M |
| 毛利率 | 61.8% | — |
| 营业利润率 | 34.6% | — |
| 净利率 | 27.6% | 23.5% |
| 营收同比 | 11.0% | -36.8% |
| 净利润同比 | 13.9% | 72.6% |
| 每股收益（稀释后） | $2.68 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RMDRNR
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.4B | $3.0B | ||
| Q3 25 | $1.3B | $3.2B | ||
| Q2 25 | $1.3B | $3.2B | ||
| Q1 25 | $1.3B | $3.5B | ||
| Q4 24 | $1.3B | $2.3B | ||
| Q3 24 | $1.2B | $4.0B | ||
| Q2 24 | $1.2B | $2.8B |
净利润RMDRNR
| Q1 26 | — | $515.8M | ||
| Q4 25 | $392.6M | $760.5M | ||
| Q3 25 | $348.5M | $916.5M | ||
| Q2 25 | $379.7M | $835.4M | ||
| Q1 25 | $365.0M | $170.0M | ||
| Q4 24 | $344.6M | $-189.7M | ||
| Q3 24 | $311.4M | $1.2B | ||
| Q2 24 | $292.2M | $503.9M |
毛利率RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | 61.8% | — | ||
| Q3 25 | 61.5% | — | ||
| Q2 25 | 60.8% | — | ||
| Q1 25 | 59.3% | — | ||
| Q4 24 | 58.6% | — | ||
| Q3 24 | 58.6% | — | ||
| Q2 24 | 58.5% | — |
营业利润率RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | 34.6% | 42.5% | ||
| Q3 25 | 33.4% | 46.3% | ||
| Q2 25 | 33.7% | 41.8% | ||
| Q1 25 | 33.0% | -2.0% | ||
| Q4 24 | 32.5% | -3.6% | ||
| Q3 24 | 31.6% | 43.7% | ||
| Q2 24 | 31.2% | 25.0% |
净利率RMDRNR
| Q1 26 | — | 23.5% | ||
| Q4 25 | 27.6% | 25.6% | ||
| Q3 25 | 26.1% | 28.7% | ||
| Q2 25 | 28.2% | 26.1% | ||
| Q1 25 | 28.3% | 4.9% | ||
| Q4 24 | 26.9% | -8.3% | ||
| Q3 24 | 25.4% | 29.8% | ||
| Q2 24 | 23.9% | 17.8% |
每股收益（稀释后）RMDRNR
| Q1 26 | — | $6.57 | ||
| Q4 25 | $2.68 | $16.16 | ||
| Q3 25 | $2.37 | $19.40 | ||
| Q2 25 | $2.58 | $17.20 | ||
| Q1 25 | $2.48 | $3.27 | ||
| Q4 24 | $2.34 | $-3.76 | ||
| Q3 24 | $2.11 | $22.62 | ||
| Q2 24 | $1.97 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $1.6B |
| 总债务越低越好 | $403.9M | — |
| 股东权益账面价值 | $6.3B | $4.3B |
| 总资产 | $8.5B | $53.7B |
| 负债/权益比越低杠杆越低 | 0.06× | — |
8季度趋势，按日历期对齐
现金及短期投资RMDRNR
| Q1 26 | — | $1.6B | ||
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $932.7M | $1.6B | ||
| Q4 24 | $521.9M | $1.7B | ||
| Q3 24 | $426.4M | $1.6B | ||
| Q2 24 | $238.4M | $1.6B |
总债务RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | $403.9M | $2.3B | ||
| Q3 25 | $408.7M | $2.2B | ||
| Q2 25 | $658.4M | $2.3B | ||
| Q1 25 | $663.1M | $2.8B | ||
| Q4 24 | $662.9M | $1.9B | ||
| Q3 24 | $667.6M | $1.9B | ||
| Q2 24 | $697.3M | $2.0B |
股东权益RMDRNR
| Q1 26 | — | $4.3B | ||
| Q4 25 | $6.3B | $11.6B | ||
| Q3 25 | $6.1B | $11.5B | ||
| Q2 25 | $6.0B | $10.8B | ||
| Q1 25 | $5.5B | $10.3B | ||
| Q4 24 | $5.3B | $10.6B | ||
| Q3 24 | $5.2B | $11.2B | ||
| Q2 24 | $4.9B | $10.2B |
总资产RMDRNR
| Q1 26 | — | $53.7B | ||
| Q4 25 | $8.5B | $53.8B | ||
| Q3 25 | $8.3B | $54.5B | ||
| Q2 25 | $8.2B | $54.7B | ||
| Q1 25 | $7.6B | $53.6B | ||
| Q4 24 | $7.1B | $50.7B | ||
| Q3 24 | $7.2B | $52.8B | ||
| Q2 24 | $6.9B | $51.6B |
负债/权益比RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | 0.06× | 0.20× | ||
| Q3 25 | 0.07× | 0.19× | ||
| Q2 25 | 0.11× | 0.21× | ||
| Q1 25 | 0.12× | 0.27× | ||
| Q4 24 | 0.13× | 0.18× | ||
| Q3 24 | 0.13× | 0.17× | ||
| Q2 24 | 0.14× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $339.7M | — |
| 自由现金流经营现金流 - 资本支出 | $311.2M | — |
| 自由现金流率自由现金流/营收 | 21.9% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 0.87× | — |
| 过去12个月自由现金流最近4个季度 | $1.8B | — |
8季度趋势，按日历期对齐
经营现金流RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | $339.7M | $483.0M | ||
| Q3 25 | $457.3M | $1.6B | ||
| Q2 25 | $538.8M | $1.5B | ||
| Q1 25 | $578.7M | $157.8M | ||
| Q4 24 | $308.6M | $778.9M | ||
| Q3 24 | $325.5M | $1.5B | ||
| Q2 24 | $440.1M | $1.2B |
自由现金流RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | $311.2M | — | ||
| Q3 25 | $414.4M | — | ||
| Q2 25 | $508.2M | — | ||
| Q1 25 | $557.9M | — | ||
| Q4 24 | $288.0M | — | ||
| Q3 24 | $307.7M | — | ||
| Q2 24 | $415.2M | — |
自由现金流率RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | — | ||
| Q3 25 | 31.0% | — | ||
| Q2 25 | 37.7% | — | ||
| Q1 25 | 43.2% | — | ||
| Q4 24 | 22.5% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 33.9% | — |
资本支出强度RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 2.0% | — |
现金转化率RMDRNR
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | 0.64× | ||
| Q3 25 | 1.31× | 1.73× | ||
| Q2 25 | 1.42× | 1.76× | ||
| Q1 25 | 1.59× | 0.93× | ||
| Q4 24 | 0.90× | — | ||
| Q3 24 | 1.05× | 1.26× | ||
| Q2 24 | 1.51× | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
RNR
暂无分部数据
